Monoamine reuptake inhibitors
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Feb 7, 2017
Issued Date -
N/A
app pub date -
Oct 12, 2011
filing date -
Apr 15, 2009
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The invention provides bupropion analog compounds capable of inhibiting the reuptake of one or more monoamines. The compounds may selectively bind to one or more monoamine transporters, including those for dopamine, norepinephrine, and serotonin. Such compounds may be used to treat conditions that are responsive to inhibition of the reuptake of monoamines, including addiction, depression, and obesity.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully